Vaccine
A vaccine is a biological preparation that
delivers immunity against any infectious disease. A vaccine usually comprises
an agent that looks like a disease-causing organism. Vaccination is a safe
& effective way to prevent persons from infectious disease before they
come into contact. Vaccination is the administration of the vaccine in the body
to help the immune system to protect from various disease.
There is 4 type of vaccines:
1. Inactivated
vaccine
2. Live
attenuated vaccine
3. Recombinant
& conjugate vaccine
4. Toxoid
vaccine
The worldwide try to form a secure and
effective COVID-19 vaccine has favourable outcomes. Some
vaccines are currently approved within the world and numerous
are under development.
For our reader’s reading simplicity,
our vaccines are categorised in table form. This provides
details of vaccines that have received regulative authorization or
approval and that are under 1-3 clinical trials.
Here is the summary of some leading vaccines in the world; -
Sr.
No. |
Vaccine
name |
Vaccine
type |
Inventors |
Origin
country |
Approval
status |
Trial
phase |
Storage |
Efficacy |
1 |
Comirnaty (BNT162b2) |
mRNA based vaccine |
Pfizer, BioNTech |
Multinational |
Approved by WHO, UK, Bahrain,
Mexico, US, Singapore, Oman, EU |
Finished |
At -70°C |
95.0% |
2 |
Moderna COVID‑19 Vaccine (mRNA1273) |
mRNA- based vaccine |
Modrena, Barda, Niaid |
USA |
Approved by US & Canada |
Finished |
At -20°C |
94.5% |
3. |
Coronavac |
Inactivated vaccine |
Sinovac |
China |
Approved by China |
Finished |
Refrigerator |
Over 50% |
4 |
Sputnik V |
Non-replicating viral vector |
Gamaleya Research Institute |
Russia |
Approved by Russia |
Finished |
Freezer storage |
91.4% |
5 |
BBIBP-CorV |
Inactivated vaccine |
Beijing Institute of biological
research |
China |
Approved by China, Bahrain, UAE |
Finished |
Unknown |
79.34% |
6 |
EpiVacCorona |
Peptide Vaccine |
Federal Budgetary Research
Institution State Research Centre of Virology and Biotechnology |
Russia |
Approved by Russia |
Finished |
Refrigerator (Up to 2 years) |
Unknown |
7 |
AZD1222 (Covishield) |
Adenovirus |
Oxford, AstraZeneca, Serum Institute
of India. |
UK, India |
Approved for emergency use in Britain & India |
Finished |
Refrigerator (Upto 6 month) |
Up to 90% |
8 |
Covaxin |
Inactivated vaccine |
Bharat Biotech, National Institute
of Virology |
India |
Approved in India |
Finished |
Room Temperature (At least 1 week) |
81% |
9 |
COVID-19 Vaccine Janssen (JNJ-78436735) |
Non-replicating viral vector |
Johnson & Johnson |
Israel |
Not Approved |
Phase 3 |
At -4°C |
Unknown |
10 |
Covidicea (Ad5nCoV) |
Adenovirus type 5 vector |
CanSino Biologics |
China |
Not Approved |
Phase 3 |
Unknown |
Unknown |
11 |
NVX-CoV2373 |
Nanoparticle vaccine |
Novavax |
US |
Not Approved |
Phase 3 |
Refrigerator |
Unknown |
12 |
No name announced |
Inactivated vaccine |
Wuhan Institute of biological
research & Sinopharm |
China |
Approved for limited use in China
& UAE |
Phase 3 |
Unknown |
Unknown |
13 |
ZyCov-D |
DNA Vaccine (Plasmid) |
Zydus Cadila |
India |
Not Approved |
Phase 3 |
Room temperature |
Unknown |
This table will be updated regularly when the vaccine status will change.
Note: Suggestions are open for any change. If you have any update, please mention in comment.
No comments:
Post a Comment